SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Reynaud S.)
 

Search: WFRF:(Reynaud S.) > (2015-2019) > Lung transplantatio...

Lung transplantation after allogeneic stem cell transplantation: a pan-European experience

Greer, M. (author)
Berastegui, C. (author)
Jaksch, P. (author)
show more...
Benden, C. (author)
Aubert, J. (author)
Roux, A. (author)
Lhuillier, E. (author)
Hirschi, S. (author)
Reynaud-Gaubert, M. (author)
Philit, F. (author)
Claustre, J. (author)
LePalud, P. (author)
Stern, M. (author)
Knoop, C. (author)
Vos, R. (author)
Verschuuren, E. (author)
Fisher, A. (author)
Riise, G. (author)
Hansson, L. (author)
Iversen, M. (author)
Hammainen, P. (author)
Wedel, Hans (author)
Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för samhällsmedicin och folkhälsa, enheten för hälsometri,Institute of Medicine, Department of Public Health and Community Medicine, Health Metrics
Smits, J. (author)
Gottlieb, J. (author)
Holm, A. M. (author)
Lhoon Jh, Chest V. P. (author)
show less...
 (creator_code:org_t)
2018-02-14
2018
English.
In: European Respiratory Journal. - : European Respiratory Society (ERS). - 0903-1936 .- 1399-3003. ; 51:2
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Late-onset noninfectious pulmonary complications (LONIPCs) affect 6% of allogeneic stem cell transplantation (SCT) recipients within 5 years, conferring subsequent 5-year survival of 50%. Lung transplantation is rarely performed in this setting due to concomitant extrapulmonary morbidity, excessive immunosuppression and concerns about recurring malignancy being considered contraindications. This study assesses survival in highly selected patients undergoing lung transplantation for LONIPCs after SCT. SCT patients undergoing lung transplantation at 20 European centres between 1996 and 2014 were included. Clinical data pre- and post-lung transplantation were reviewed. Propensity score-matched controls were generated from the Eurotransplant and Scandiatransplant registries. Kaplan-Meier survival analysis and Cox proportional hazard regression models evaluating predictors of graft loss were performed. Graft survival at 1, 3 and 5 years of 84%, 72% and 67%, respectively, among the 105 SCT patients proved comparable to controls (p=0.75). Sepsis accounted for 15 out of 37 deaths (41%), with prior mechanical ventilation (HR 6.9, 95% CI 1.0-46.7; p<0.001) the leading risk factor. No SCT-specific risk factors were identified. Recurring malignancy occurred in four patients (4%). Lung transplantation <2 years post-SCT increased all-cause 1-year mortality (HR 7.5, 95% CI 2.3-23.8; p=0.001). Lung transplantation outcomes following SCT were comparable to other end-stage diseases. Lung transplantation should be considered feasible in selected candidates. No SCT-specific factors influencing outcome were identified within this carefully selected patient cohort.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Keyword

versus-host-disease
bronchiolitis-obliterans-syndrome
acute
lymphoblastic-leukemia
allograft dysfunction
international society
allo-sct
mortality
children
criteria
update
Respiratory System

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view